Richard Okita, Ph.D., is a program director in the Division of Pharmacology, Physiology, and Biological Chemistry, where he administers grants in the areas of drug metabolism and transport, drug-induced toxicology and drug delivery. He also manages predoctoral T32 pharmacological sciences and postdoctoral T32 clinical pharmacology training grants, F32 postdoctoral fellowships in the pharmacological sciences, anesthesiology and clinical pharmacology; and trauma, burn and perioperative injury, and mentored career development awards in clinical pharmacology. He also manages the Building Infrastructure Leading to Diversity (BUILD) Initiative. Prior to joining NIGMS, Okita was a professor of pharmaceutical sciences at Washington State University. He earned a B.A. in bacteriology from the University of California, Los Angeles, and a Ph.D. in biochemical pharmacology from the University of Southern California. Okita conducted postdoctoral research at the University of Texas Health Science Center at Dallas.
To contact Richard Okita, send email to firstname.lastname@example.org or call 301-594-3827. If you’re a reporter wishing to interview him, contact the NIGMS Office of Communications and Public Liaison at email@example.com or call 301-496-7301.